Related references
Note: Only part of the references are listed.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy et al.
CLINICAL RHEUMATOLOGY (2020)
Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection
Hua Shi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Extra-respiratory manifestations of COVID-19
Chih-Cheng Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
Yun Xie et al.
JOURNAL OF INFECTION (2020)
Cutaneous manifestations in COVID-19: a first perspective
S. Recalcati
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Mauro Panigada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
Alan A. Nguyen et al.
CLINICAL IMMUNOLOGY (2020)
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
Xiaosheng Liu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cardiac MRI in Children with Multisystem Inflammatory Syndrome Associated with COVID-19
Eleonore Blondiaux et al.
RADIOLOGY (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020
Sapna Bamrah Morris et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Min Seo Kim et al.
PLOS MEDICINE (2020)
COVID-19 and multisystem inflammatory syndrome in children and adolescents
Li Jiang et al.
LANCET INFECTIOUS DISEASES (2020)
Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study
Ziyun Shao et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Adverse Effects of Immunoglobulin Therapy
Yi Guo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the Way
Bo Shopsin et al.
CELL HOST & MICROBE (2016)
IVIG-mediated protection against necrotizing pneumonia caused by MRSA
Binh An Diep et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation
Mohan S. Maddur et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Coronavirus Associated Fulminant Myocarditis Successfully Treated With Intravenous Immunoglobulin and Extracorporeal Membrane Oxygenation
Sangeetha Rao et al.
CHEST (2014)
Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells
Jamma Trinath et al.
BLOOD (2013)
Hyperimmune IV Immunoglobulin Treatment A Multicenter Double-Blind Randomized Controlled Trial for Patients With Severe 2009 Influenza A(H1N1) Infection
Ivan F. N. Hung et al.
CHEST (2013)
Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy
S. V. Kaveri et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
What is the contents of the magic draft IVIg?
Jean-Francois Seite et al.
AUTOIMMUNITY REVIEWS (2008)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
Inhibition of human coronavirus NL63 infection at early stages of the replication cycle
Krzysztof Pyrc et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Clinical uses of intravenous immunoglobulin
S Jolles et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?
J Bayry et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Side effects of intravenous immunoglobulins in neurological autoimmune disorders - A prospective study
M Stangel et al.
JOURNAL OF NEUROLOGY (2003)
In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations -: a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases
I Krause et al.
TRANSFUSION MEDICINE (2002)
Share Paper
